Wird geladen...
Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands
Vaccine efficacy is optimized by addition of immune adjuvants. However, although adjuvants have been used for over a century, to date, only few adjuvants are approved for human use, mostly aimed at improving vaccine efficacy and antigen-specific protective antibody production. The mechanism of actio...
Gespeichert in:
| Veröffentlicht in: | Vaccines (Basel) |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494261/ https://ncbi.nlm.nih.gov/pubmed/26344622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines2020323 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|